Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
OMDA · against 467 other Healthcare companies of similar size
Ranked #312 of 468 · scores higher than 32% of peers
Bars: peers in each 10-point band of the valuation score35 peers with a valuation score of 30–39, including OMDA · Click a bar to see the companies
Mainly because of its EBITDA yield, which is weaker than most Healthcare peers.
| Metric | OMDA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 458 reported | 1.3% | 1.4% | 49% | 30% | |
| EBITDA yieldHigher is better · 472 reported | 0.6% | 4.3% | 33% | 50% | |
| Free cash flow yieldHigher is better · 204 reported | 1.5% | -1.6% | 64% | 20% | |
| Book yieldHigher is better · 463 reported | 22.4% | 40.8% | 25% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 40.2B MXN (≈$2.2B) | 99 | 71 | |
| 312 | 1.86T KRW (≈$1.3B) | 32 | 43 | |
| 312 | 6.0B CNY (≈$840M) | 32 | 35 | |
| 312 | 4.7B CNY (≈$653M) | 32 | 52 | |
| 312 | 6.0B CNY (≈$840M) | 32 | 45 | |
| 312 | 1.1B USD | 32 | 61 | |
| 312 | 1.9B NZD (≈$1.1B) | 32 | 42 | |
| 312 | 1.5B EUR (≈$1.6B) | 32 | 44 | |
| 312 | 871M USD | 32 | 53 | |
| 321 | 2.2B USD | 31 | 36 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score